A qualitative study of 60 allergists shows widespread enthusiasm for biological therapies in food allergy treatment, particularly following omalizumab's recent FDA approval.

A comprehensive analysis of 132 studies reveals 45.3% of type 2 diabetes patients suffer from multiple micronutrient deficiencies, with vitamin D deficiency affecting 60.45% of patients.

Mayo Clinic experts discuss the growing role of cannabis in cancer symptom management, highlighting different strains and delivery systems while noting limited clinical evidence for pain and nausea control.

A large-scale US study reveals that every 5 parts per billion increase in nitrogen dioxide exposure is associated with a 21% higher risk of ovarian cancer development.

A comprehensive 21-year study reveals that body-weight cycling, or yo-yo dieting, significantly increases the risk of kidney function decline in patients with type 1 diabetes.

Yale researchers have developed JomCare, an innovative mobile app designed to reduce HIV transmission risk by targeting sexualized drug use behaviors among gay and bisexual men.

Clinical trials significantly underrepresent America's diverse population, with particular challenges in engaging Black patients due to historical trust issues in medical interventions.

A large-scale SEER database study reveals patients with prior malignancy history showed significantly better cancer-specific survival rates in metastatic colorectal cancer compared to those without prior cancer.

Leading transplant specialists highlight the critical importance of collaboration between transplant centers and referring physicians in managing chronic graft-versus-host disease (GVHD) patients.

CAR T-cell therapy and bispecific antibodies have transformed hematologic malignancy treatment, offering new hope beyond traditional chemotherapy and targeted drugs.

A large VA healthcare system study reveals that direct-acting antiviral (DAA) therapy significantly reduces hepatocellular carcinoma risk compared to no treatment in HCV patients with cirrhosis.

A novel evaluation index system, developed within the Enhanced Recovery After Surgery framework, demonstrates effectiveness in optimizing hospital discharge timing for colorectal cancer patients.

Real-world analysis of 18,396 MASH patients reveals that only 10% underwent liver biopsy for diagnosis, while noninvasive testing combinations have become the predominant diagnostic approach.

Leading experts at the 2025 Transplant and Cellular Therapy Meetings emphasize the critical need to address social vulnerabilities affecting patient access to stem cell transplants and CAR T-cell therapies.

Dr. Lidia Schapira emphasizes that effective shared decision-making in breast cancer care requires mutual respect and clear communication between clinicians and patients, with adequate time for informed choices.

Despite demonstrating a 7% improvement in 5-year overall survival, neoadjuvant chemotherapy followed by surgery is utilized in only 19% of primary urethral cancer patients.

The National Alkaptonuria Centre (NAC) and DevelopAKUre clinical trials face significant recruitment challenges, needing to identify patients from a limited global pool of only 1,000 known cases.

A British Columbia study reveals that despite overall improvements in HIV life expectancy from 1996-2020, women consistently lag behind men, with the gender gap increasing to 7.05 years by 2020.

Leading oncologist from City of Hope Cancer Center highlights urgent need for cost-effectiveness studies in hematologic malignancy treatments to optimize healthcare resource utilization.

Osivax secures €10 million in Series B financing, with strategic investment from Japanese pharmaceutical leader Meiji Seika Pharma, to accelerate development of broad-spectrum influenza vaccine candidates.